NEWLIMIT

Live / Applied — Fifth extension granted (statement of use) (as of 07 Feb 2026)

What this means for you

Not registered yet, but its 27 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97047942
Mark type
Stylized text
Filed
27 Sept 2021
Published for opposition
31 Jan 2023
Attorney of record
Perry J. Viscounty

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the diagnosis, prevention and treatment of central nervous system, cardio-vascular, metabolic, hepatic, nephrologic, orthopedic, muscular, immunologic and auto-immunologic, dermatologic, pulmonary, respiratory, oncologic, inflammatory, infectious, ophthalmologic, auditory, genetic, and aging-related and gerontologic diseases and disorders; biological preparations for use in the diagnosis, prevention and treatment of central nervous system, cardio-vascular, metabolic, hepatic, nephrologic, orthopedic, muscular, immunologic and auto-immunologic, dermatologic, pulmonary, respiratory, oncologic, inflammatory, infectious, ophthalmologic, auditory, genetic, and aging-related and gerontologic diseases and disorders; gene therapy products for use in the diagnosis, prevention and treatment of central nervous system, cardio-vascular, metabolic, hepatic, nephrologic, orthopedic, muscular, immunologic and auto-immunologic, dermatologic, pulmonary, respiratory, oncologic, inflammatory, infectious, ophthalmologic, auditory, genetic, and aging-related and gerontologic diseases and disorders
  • Class 042 — Scientific and technological services: Scientific and medical research and development services; providing information about scientific and medical research; development of pharmaceutical and biological preparations for gene therapy
  • Class 044 — Medical, beauty and agricultural services: Medical services; providing information in the fields of health and wellness

Owner

Prosecution history

  • 07 Feb 2026 — SOU EXTENSION 5 GRANTED
  • 15 Sept 2025 — SOU EXTENSION 5 FILED
  • 30 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 15 Sept 2025 — SOU TEAS EXTENSION RECEIVED
  • 20 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 19 Feb 2025 — SOU EXTENSION 4 GRANTED
  • 19 Feb 2025 — SOU EXTENSION 4 FILED
  • 19 Feb 2025 — SOU TEAS EXTENSION RECEIVED
  • 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 25 Sept 2024 — SOU EXTENSION 3 GRANTED
  • 25 Sept 2024 — SOU EXTENSION 3 FILED
  • 25 Sept 2024 — SOU TEAS EXTENSION RECEIVED
  • 27 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 26 Mar 2024 — SOU EXTENSION 2 GRANTED
  • 26 Mar 2024 — SOU EXTENSION 2 FILED

View this trademark record on Marksy